Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Improving Quality of Care: Workshop Summary

Free Books & Documents
Review

Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa: Reducing the Treatment Gap, Improving Quality of Care: Workshop Summary

Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders et al.
Free Books & Documents

Excerpt

In August 2009 the Uganda National Academy of Sciences Forum on Health and Nutrition and the U.S. Institute of Medicine’s Forum on Neuroscience and Neurological Disorders jointly hosted a workshop in Kampala, Uganda, titled Quality of Care Issues for Mental Health and Neurological Disorders in Sub-Saharan Africa. More than 150 researchers, providers, patient advocates, and policy specialists came together to discuss the current state of care for mental, neurological, and substance use disorders in sub-Saharan Africa. The goal was to uncover strategies to improve the quality and consistency of care delivered in sub-Saharan Africa, taking into account resource constraints, infrastructure limitations, and other realities. Workshop speakers were charged to do the following:

  1. Discuss opportunities to ensure continuity of care and provide sustainable care within a country’s existing healthcare system.

  2. Identify resources that are either currently available, or that could be made available in cost-effective and efficient ways, to aid in the treatment and prevention of disease.

  3. Examine the need for national, evidence-based policies within national healthcare systems that address quality-of-care issues for mental, neurological, and substance use disorders.

  4. Explore opportunities to facilitate collaborations among a variety of stakeholders, including policy makers and healthcare professionals.

PubMed Disclaimer

Grants and funding

This project was supported by contracts between the National Academy of Sciences and the Alzheimer’s Association; AstraZeneca Pharmaceuticals, Inc.; CeNeRx Biopharma; the Department of Health and Human Services’ National Institutes of Health (NIH, Contract Nos. N01-OD-4-213, N01-OD-4-2139) through the National Institute on Aging, the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the National Eye Institute, the NIH Blueprint for Neuroscience Research, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke; Eli Lilly and Company; GE Healthcare, Inc.; GlaxoSmithKline, Inc.; Johnson & Johnson Pharmaceutical Research and Development, LLC; Merck Research Laboratories; the National Multiple Sclerosis Society; the National Science Foundation (Contract No. OIA-0753701); the Society for Neuroscience; and Wyeth Research, Inc.

LinkOut - more resources